Global Preventive Medicine for Pets Market Growth 2026-2032
The global Preventive Medicine for Pets market size is predicted to grow from US$ 1122 million in 2025 to US$ 1940 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032.
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
LP Information, Inc. (LPI) ' newest research report, the ?Preventive Medicine for Pets Industry Forecast? looks at past sales and reviews total world Preventive Medicine for Pets sales in 2025, providing a comprehensive analysis by region and market sector of projected Preventive Medicine for Pets sales for 2026 through 2032. With Preventive Medicine for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventive Medicine for Pets industry.
This Insight Report provides a comprehensive analysis of the global Preventive Medicine for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventive Medicine for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Preventive Medicine for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventive Medicine for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventive Medicine for Pets.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Medicine for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
LP Information, Inc. (LPI) ' newest research report, the ?Preventive Medicine for Pets Industry Forecast? looks at past sales and reviews total world Preventive Medicine for Pets sales in 2025, providing a comprehensive analysis by region and market sector of projected Preventive Medicine for Pets sales for 2026 through 2032. With Preventive Medicine for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventive Medicine for Pets industry.
This Insight Report provides a comprehensive analysis of the global Preventive Medicine for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventive Medicine for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Preventive Medicine for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventive Medicine for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventive Medicine for Pets.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Medicine for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Powder
- Liquid
- Cat
- Dog
- Reptile
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Boehringer Ingelheim
- Merck
- Elanco
- Virbac
- Dechra Veterinary Products
- Ceva
- Vetoquinol
- Ouro Fino Saude
- Norbrook
- Jindun
- Wuhan chopperlvya
- CAHIC
- What is the 10-year outlook for the global Preventive Medicine for Pets market?
- What factors are driving Preventive Medicine for Pets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Preventive Medicine for Pets market opportunities vary by end market size?
- How does Preventive Medicine for Pets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preventive Medicine for Pets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Preventive Medicine for Pets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Preventive Medicine for Pets by Country/Region, 2021, 2025 & 2032
2.2 Preventive Medicine for Pets Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Preventive Medicine for Pets Sales by Type
2.2.3.1 Global Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Preventive Medicine for Pets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Preventive Medicine for Pets Sale Price by Type (2021-2026)
2.3 Preventive Medicine for Pets Segment by Application
2.3.1 Cat
2.3.2 Dog
2.3.3 Reptile
2.3.4 Other
2.3.5 Preventive Medicine for Pets Sales by Application
2.3.5.1 Global Preventive Medicine for Pets Sale Market Share by Application (2021-2026)
2.3.5.2 Global Preventive Medicine for Pets Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Preventive Medicine for Pets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Preventive Medicine for Pets Breakdown Data by Company
3.1.1 Global Preventive Medicine for Pets Annual Sales by Company (2021-2026)
3.1.2 Global Preventive Medicine for Pets Sales Market Share by Company (2021-2026)
3.2 Global Preventive Medicine for Pets Annual Revenue by Company (2021-2026)
3.2.1 Global Preventive Medicine for Pets Revenue by Company (2021-2026)
3.2.2 Global Preventive Medicine for Pets Revenue Market Share by Company (2021-2026)
3.3 Global Preventive Medicine for Pets Sale Price by Company
3.4 Key Manufacturers Preventive Medicine for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventive Medicine for Pets Product Location Distribution
3.4.2 Players Preventive Medicine for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PREVENTIVE MEDICINE FOR PETS BY GEOGRAPHIC REGION
4.1 World Historic Preventive Medicine for Pets Market Size by Geographic Region (2021-2026)
4.1.1 Global Preventive Medicine for Pets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Preventive Medicine for Pets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Preventive Medicine for Pets Market Size by Country/Region (2021-2026)
4.2.1 Global Preventive Medicine for Pets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Preventive Medicine for Pets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Preventive Medicine for Pets Sales Growth
4.4 APAC Preventive Medicine for Pets Sales Growth
4.5 Europe Preventive Medicine for Pets Sales Growth
4.6 Middle East & Africa Preventive Medicine for Pets Sales Growth
5 AMERICAS
5.1 Americas Preventive Medicine for Pets Sales by Country
5.1.1 Americas Preventive Medicine for Pets Sales by Country (2021-2026)
5.1.2 Americas Preventive Medicine for Pets Revenue by Country (2021-2026)
5.2 Americas Preventive Medicine for Pets Sales by Type (2021-2026)
5.3 Americas Preventive Medicine for Pets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventive Medicine for Pets Sales by Region
6.1.1 APAC Preventive Medicine for Pets Sales by Region (2021-2026)
6.1.2 APAC Preventive Medicine for Pets Revenue by Region (2021-2026)
6.2 APAC Preventive Medicine for Pets Sales by Type (2021-2026)
6.3 APAC Preventive Medicine for Pets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Preventive Medicine for Pets by Country
7.1.1 Europe Preventive Medicine for Pets Sales by Country (2021-2026)
7.1.2 Europe Preventive Medicine for Pets Revenue by Country (2021-2026)
7.2 Europe Preventive Medicine for Pets Sales by Type (2021-2026)
7.3 Europe Preventive Medicine for Pets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preventive Medicine for Pets by Country
8.1.1 Middle East & Africa Preventive Medicine for Pets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Preventive Medicine for Pets Revenue by Country (2021-2026)
8.2 Middle East & Africa Preventive Medicine for Pets Sales by Type (2021-2026)
8.3 Middle East & Africa Preventive Medicine for Pets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventive Medicine for Pets
10.3 Manufacturing Process Analysis of Preventive Medicine for Pets
10.4 Industry Chain Structure of Preventive Medicine for Pets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventive Medicine for Pets Distributors
11.3 Preventive Medicine for Pets Customer
12 WORLD FORECAST REVIEW FOR PREVENTIVE MEDICINE FOR PETS BY GEOGRAPHIC REGION
12.1 Global Preventive Medicine for Pets Market Size Forecast by Region
12.1.1 Global Preventive Medicine for Pets Forecast by Region (2027-2032)
12.1.2 Global Preventive Medicine for Pets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Preventive Medicine for Pets Forecast by Type (2027-2032)
12.7 Global Preventive Medicine for Pets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Preventive Medicine for Pets Product Portfolios and Specifications
13.1.3 Zoetis Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Preventive Medicine for Pets Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Preventive Medicine for Pets Product Portfolios and Specifications
13.3.3 Merck Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Preventive Medicine for Pets Product Portfolios and Specifications
13.4.3 Elanco Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Preventive Medicine for Pets Product Portfolios and Specifications
13.5.3 Virbac Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Preventive Medicine for Pets Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Preventive Medicine for Pets Product Portfolios and Specifications
13.7.3 Ceva Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Preventive Medicine for Pets Product Portfolios and Specifications
13.8.3 Vetoquinol Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Ouro Fino Saude
13.9.1 Ouro Fino Saude Company Information
13.9.2 Ouro Fino Saude Preventive Medicine for Pets Product Portfolios and Specifications
13.9.3 Ouro Fino Saude Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ouro Fino Saude Main Business Overview
13.9.5 Ouro Fino Saude Latest Developments
13.10 Norbrook
13.10.1 Norbrook Company Information
13.10.2 Norbrook Preventive Medicine for Pets Product Portfolios and Specifications
13.10.3 Norbrook Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Norbrook Main Business Overview
13.10.5 Norbrook Latest Developments
13.11 Jindun
13.11.1 Jindun Company Information
13.11.2 Jindun Preventive Medicine for Pets Product Portfolios and Specifications
13.11.3 Jindun Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jindun Main Business Overview
13.11.5 Jindun Latest Developments
13.12 Wuhan chopperlvya
13.12.1 Wuhan chopperlvya Company Information
13.12.2 Wuhan chopperlvya Preventive Medicine for Pets Product Portfolios and Specifications
13.12.3 Wuhan chopperlvya Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Wuhan chopperlvya Main Business Overview
13.12.5 Wuhan chopperlvya Latest Developments
13.13 CAHIC
13.13.1 CAHIC Company Information
13.13.2 CAHIC Preventive Medicine for Pets Product Portfolios and Specifications
13.13.3 CAHIC Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 CAHIC Main Business Overview
13.13.5 CAHIC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preventive Medicine for Pets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Preventive Medicine for Pets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Preventive Medicine for Pets by Country/Region, 2021, 2025 & 2032
2.2 Preventive Medicine for Pets Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Preventive Medicine for Pets Sales by Type
2.2.3.1 Global Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Preventive Medicine for Pets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Preventive Medicine for Pets Sale Price by Type (2021-2026)
2.3 Preventive Medicine for Pets Segment by Application
2.3.1 Cat
2.3.2 Dog
2.3.3 Reptile
2.3.4 Other
2.3.5 Preventive Medicine for Pets Sales by Application
2.3.5.1 Global Preventive Medicine for Pets Sale Market Share by Application (2021-2026)
2.3.5.2 Global Preventive Medicine for Pets Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Preventive Medicine for Pets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Preventive Medicine for Pets Breakdown Data by Company
3.1.1 Global Preventive Medicine for Pets Annual Sales by Company (2021-2026)
3.1.2 Global Preventive Medicine for Pets Sales Market Share by Company (2021-2026)
3.2 Global Preventive Medicine for Pets Annual Revenue by Company (2021-2026)
3.2.1 Global Preventive Medicine for Pets Revenue by Company (2021-2026)
3.2.2 Global Preventive Medicine for Pets Revenue Market Share by Company (2021-2026)
3.3 Global Preventive Medicine for Pets Sale Price by Company
3.4 Key Manufacturers Preventive Medicine for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventive Medicine for Pets Product Location Distribution
3.4.2 Players Preventive Medicine for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PREVENTIVE MEDICINE FOR PETS BY GEOGRAPHIC REGION
4.1 World Historic Preventive Medicine for Pets Market Size by Geographic Region (2021-2026)
4.1.1 Global Preventive Medicine for Pets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Preventive Medicine for Pets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Preventive Medicine for Pets Market Size by Country/Region (2021-2026)
4.2.1 Global Preventive Medicine for Pets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Preventive Medicine for Pets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Preventive Medicine for Pets Sales Growth
4.4 APAC Preventive Medicine for Pets Sales Growth
4.5 Europe Preventive Medicine for Pets Sales Growth
4.6 Middle East & Africa Preventive Medicine for Pets Sales Growth
5 AMERICAS
5.1 Americas Preventive Medicine for Pets Sales by Country
5.1.1 Americas Preventive Medicine for Pets Sales by Country (2021-2026)
5.1.2 Americas Preventive Medicine for Pets Revenue by Country (2021-2026)
5.2 Americas Preventive Medicine for Pets Sales by Type (2021-2026)
5.3 Americas Preventive Medicine for Pets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventive Medicine for Pets Sales by Region
6.1.1 APAC Preventive Medicine for Pets Sales by Region (2021-2026)
6.1.2 APAC Preventive Medicine for Pets Revenue by Region (2021-2026)
6.2 APAC Preventive Medicine for Pets Sales by Type (2021-2026)
6.3 APAC Preventive Medicine for Pets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Preventive Medicine for Pets by Country
7.1.1 Europe Preventive Medicine for Pets Sales by Country (2021-2026)
7.1.2 Europe Preventive Medicine for Pets Revenue by Country (2021-2026)
7.2 Europe Preventive Medicine for Pets Sales by Type (2021-2026)
7.3 Europe Preventive Medicine for Pets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preventive Medicine for Pets by Country
8.1.1 Middle East & Africa Preventive Medicine for Pets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Preventive Medicine for Pets Revenue by Country (2021-2026)
8.2 Middle East & Africa Preventive Medicine for Pets Sales by Type (2021-2026)
8.3 Middle East & Africa Preventive Medicine for Pets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventive Medicine for Pets
10.3 Manufacturing Process Analysis of Preventive Medicine for Pets
10.4 Industry Chain Structure of Preventive Medicine for Pets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventive Medicine for Pets Distributors
11.3 Preventive Medicine for Pets Customer
12 WORLD FORECAST REVIEW FOR PREVENTIVE MEDICINE FOR PETS BY GEOGRAPHIC REGION
12.1 Global Preventive Medicine for Pets Market Size Forecast by Region
12.1.1 Global Preventive Medicine for Pets Forecast by Region (2027-2032)
12.1.2 Global Preventive Medicine for Pets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Preventive Medicine for Pets Forecast by Type (2027-2032)
12.7 Global Preventive Medicine for Pets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Preventive Medicine for Pets Product Portfolios and Specifications
13.1.3 Zoetis Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Preventive Medicine for Pets Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Preventive Medicine for Pets Product Portfolios and Specifications
13.3.3 Merck Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Preventive Medicine for Pets Product Portfolios and Specifications
13.4.3 Elanco Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Preventive Medicine for Pets Product Portfolios and Specifications
13.5.3 Virbac Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Preventive Medicine for Pets Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Preventive Medicine for Pets Product Portfolios and Specifications
13.7.3 Ceva Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Preventive Medicine for Pets Product Portfolios and Specifications
13.8.3 Vetoquinol Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Ouro Fino Saude
13.9.1 Ouro Fino Saude Company Information
13.9.2 Ouro Fino Saude Preventive Medicine for Pets Product Portfolios and Specifications
13.9.3 Ouro Fino Saude Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ouro Fino Saude Main Business Overview
13.9.5 Ouro Fino Saude Latest Developments
13.10 Norbrook
13.10.1 Norbrook Company Information
13.10.2 Norbrook Preventive Medicine for Pets Product Portfolios and Specifications
13.10.3 Norbrook Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Norbrook Main Business Overview
13.10.5 Norbrook Latest Developments
13.11 Jindun
13.11.1 Jindun Company Information
13.11.2 Jindun Preventive Medicine for Pets Product Portfolios and Specifications
13.11.3 Jindun Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jindun Main Business Overview
13.11.5 Jindun Latest Developments
13.12 Wuhan chopperlvya
13.12.1 Wuhan chopperlvya Company Information
13.12.2 Wuhan chopperlvya Preventive Medicine for Pets Product Portfolios and Specifications
13.12.3 Wuhan chopperlvya Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Wuhan chopperlvya Main Business Overview
13.12.5 Wuhan chopperlvya Latest Developments
13.13 CAHIC
13.13.1 CAHIC Company Information
13.13.2 CAHIC Preventive Medicine for Pets Product Portfolios and Specifications
13.13.3 CAHIC Preventive Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 CAHIC Main Business Overview
13.13.5 CAHIC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Preventive Medicine for Pets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Preventive Medicine for Pets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 6. Global Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Table 7. Global Preventive Medicine for Pets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Preventive Medicine for Pets Revenue Market Share by Type (2021-2026)
Table 9. Global Preventive Medicine for Pets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Preventive Medicine for Pets Sale by Application (2021-2026) & (K Units)
Table 11. Global Preventive Medicine for Pets Sale Market Share by Application (2021-2026)
Table 12. Global Preventive Medicine for Pets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Preventive Medicine for Pets Revenue Market Share by Application (2021-2026)
Table 14. Global Preventive Medicine for Pets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Preventive Medicine for Pets Sales by Company (2021-2026) & (K Units)
Table 16. Global Preventive Medicine for Pets Sales Market Share by Company (2021-2026)
Table 17. Global Preventive Medicine for Pets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Preventive Medicine for Pets Revenue Market Share by Company (2021-2026)
Table 19. Global Preventive Medicine for Pets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Preventive Medicine for Pets Producing Area Distribution and Sales Area
Table 21. Players Preventive Medicine for Pets Products Offered
Table 22. Preventive Medicine for Pets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Preventive Medicine for Pets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Preventive Medicine for Pets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Preventive Medicine for Pets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Preventive Medicine for Pets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Preventive Medicine for Pets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Preventive Medicine for Pets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Preventive Medicine for Pets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Preventive Medicine for Pets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Preventive Medicine for Pets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Preventive Medicine for Pets Sales Market Share by Country (2021-2026)
Table 35. Americas Preventive Medicine for Pets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Preventive Medicine for Pets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Preventive Medicine for Pets Sales Market Share by Region (2021-2026)
Table 40. APAC Preventive Medicine for Pets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Preventive Medicine for Pets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Preventive Medicine for Pets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Preventive Medicine for Pets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Preventive Medicine for Pets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Preventive Medicine for Pets
Table 52. Key Market Challenges & Risks of Preventive Medicine for Pets
Table 53. Key Industry Trends of Preventive Medicine for Pets
Table 54. Preventive Medicine for Pets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Preventive Medicine for Pets Distributors List
Table 57. Preventive Medicine for Pets Customer List
Table 58. Global Preventive Medicine for Pets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Preventive Medicine for Pets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Preventive Medicine for Pets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Preventive Medicine for Pets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Preventive Medicine for Pets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Preventive Medicine for Pets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Preventive Medicine for Pets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Preventive Medicine for Pets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Preventive Medicine for Pets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Preventive Medicine for Pets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Preventive Medicine for Pets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Preventive Medicine for Pets Product Portfolios and Specifications
Table 74. Zoetis Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Preventive Medicine for Pets Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Merck Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Preventive Medicine for Pets Product Portfolios and Specifications
Table 84. Merck Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Elanco Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Preventive Medicine for Pets Product Portfolios and Specifications
Table 89. Elanco Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elanco Main Business
Table 91. Elanco Latest Developments
Table 92. Virbac Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 93. Virbac Preventive Medicine for Pets Product Portfolios and Specifications
Table 94. Virbac Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Virbac Main Business
Table 96. Virbac Latest Developments
Table 97. Dechra Veterinary Products Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 98. Dechra Veterinary Products Preventive Medicine for Pets Product Portfolios and Specifications
Table 99. Dechra Veterinary Products Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dechra Veterinary Products Main Business
Table 101. Dechra Veterinary Products Latest Developments
Table 102. Ceva Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Preventive Medicine for Pets Product Portfolios and Specifications
Table 104. Ceva Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ceva Main Business
Table 106. Ceva Latest Developments
Table 107. Vetoquinol Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 108. Vetoquinol Preventive Medicine for Pets Product Portfolios and Specifications
Table 109. Vetoquinol Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Vetoquinol Main Business
Table 111. Vetoquinol Latest Developments
Table 112. Ouro Fino Saude Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 113. Ouro Fino Saude Preventive Medicine for Pets Product Portfolios and Specifications
Table 114. Ouro Fino Saude Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Ouro Fino Saude Main Business
Table 116. Ouro Fino Saude Latest Developments
Table 117. Norbrook Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 118. Norbrook Preventive Medicine for Pets Product Portfolios and Specifications
Table 119. Norbrook Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Norbrook Main Business
Table 121. Norbrook Latest Developments
Table 122. Jindun Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 123. Jindun Preventive Medicine for Pets Product Portfolios and Specifications
Table 124. Jindun Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jindun Main Business
Table 126. Jindun Latest Developments
Table 127. Wuhan chopperlvya Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 128. Wuhan chopperlvya Preventive Medicine for Pets Product Portfolios and Specifications
Table 129. Wuhan chopperlvya Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Wuhan chopperlvya Main Business
Table 131. Wuhan chopperlvya Latest Developments
Table 132. CAHIC Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 133. CAHIC Preventive Medicine for Pets Product Portfolios and Specifications
Table 134. CAHIC Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. CAHIC Main Business
Table 136. CAHIC Latest Developments
Table 1. Preventive Medicine for Pets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Preventive Medicine for Pets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 6. Global Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Table 7. Global Preventive Medicine for Pets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Preventive Medicine for Pets Revenue Market Share by Type (2021-2026)
Table 9. Global Preventive Medicine for Pets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Preventive Medicine for Pets Sale by Application (2021-2026) & (K Units)
Table 11. Global Preventive Medicine for Pets Sale Market Share by Application (2021-2026)
Table 12. Global Preventive Medicine for Pets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Preventive Medicine for Pets Revenue Market Share by Application (2021-2026)
Table 14. Global Preventive Medicine for Pets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Preventive Medicine for Pets Sales by Company (2021-2026) & (K Units)
Table 16. Global Preventive Medicine for Pets Sales Market Share by Company (2021-2026)
Table 17. Global Preventive Medicine for Pets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Preventive Medicine for Pets Revenue Market Share by Company (2021-2026)
Table 19. Global Preventive Medicine for Pets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Preventive Medicine for Pets Producing Area Distribution and Sales Area
Table 21. Players Preventive Medicine for Pets Products Offered
Table 22. Preventive Medicine for Pets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Preventive Medicine for Pets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Preventive Medicine for Pets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Preventive Medicine for Pets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Preventive Medicine for Pets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Preventive Medicine for Pets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Preventive Medicine for Pets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Preventive Medicine for Pets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Preventive Medicine for Pets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Preventive Medicine for Pets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Preventive Medicine for Pets Sales Market Share by Country (2021-2026)
Table 35. Americas Preventive Medicine for Pets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Preventive Medicine for Pets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Preventive Medicine for Pets Sales Market Share by Region (2021-2026)
Table 40. APAC Preventive Medicine for Pets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Preventive Medicine for Pets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Preventive Medicine for Pets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Preventive Medicine for Pets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Preventive Medicine for Pets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Preventive Medicine for Pets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Preventive Medicine for Pets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Preventive Medicine for Pets
Table 52. Key Market Challenges & Risks of Preventive Medicine for Pets
Table 53. Key Industry Trends of Preventive Medicine for Pets
Table 54. Preventive Medicine for Pets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Preventive Medicine for Pets Distributors List
Table 57. Preventive Medicine for Pets Customer List
Table 58. Global Preventive Medicine for Pets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Preventive Medicine for Pets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Preventive Medicine for Pets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Preventive Medicine for Pets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Preventive Medicine for Pets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Preventive Medicine for Pets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Preventive Medicine for Pets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Preventive Medicine for Pets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Preventive Medicine for Pets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Preventive Medicine for Pets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Preventive Medicine for Pets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Preventive Medicine for Pets Product Portfolios and Specifications
Table 74. Zoetis Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Preventive Medicine for Pets Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Merck Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Preventive Medicine for Pets Product Portfolios and Specifications
Table 84. Merck Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Elanco Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Preventive Medicine for Pets Product Portfolios and Specifications
Table 89. Elanco Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elanco Main Business
Table 91. Elanco Latest Developments
Table 92. Virbac Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 93. Virbac Preventive Medicine for Pets Product Portfolios and Specifications
Table 94. Virbac Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Virbac Main Business
Table 96. Virbac Latest Developments
Table 97. Dechra Veterinary Products Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 98. Dechra Veterinary Products Preventive Medicine for Pets Product Portfolios and Specifications
Table 99. Dechra Veterinary Products Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dechra Veterinary Products Main Business
Table 101. Dechra Veterinary Products Latest Developments
Table 102. Ceva Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Preventive Medicine for Pets Product Portfolios and Specifications
Table 104. Ceva Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ceva Main Business
Table 106. Ceva Latest Developments
Table 107. Vetoquinol Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 108. Vetoquinol Preventive Medicine for Pets Product Portfolios and Specifications
Table 109. Vetoquinol Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Vetoquinol Main Business
Table 111. Vetoquinol Latest Developments
Table 112. Ouro Fino Saude Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 113. Ouro Fino Saude Preventive Medicine for Pets Product Portfolios and Specifications
Table 114. Ouro Fino Saude Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Ouro Fino Saude Main Business
Table 116. Ouro Fino Saude Latest Developments
Table 117. Norbrook Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 118. Norbrook Preventive Medicine for Pets Product Portfolios and Specifications
Table 119. Norbrook Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Norbrook Main Business
Table 121. Norbrook Latest Developments
Table 122. Jindun Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 123. Jindun Preventive Medicine for Pets Product Portfolios and Specifications
Table 124. Jindun Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jindun Main Business
Table 126. Jindun Latest Developments
Table 127. Wuhan chopperlvya Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 128. Wuhan chopperlvya Preventive Medicine for Pets Product Portfolios and Specifications
Table 129. Wuhan chopperlvya Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Wuhan chopperlvya Main Business
Table 131. Wuhan chopperlvya Latest Developments
Table 132. CAHIC Basic Information, Preventive Medicine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 133. CAHIC Preventive Medicine for Pets Product Portfolios and Specifications
Table 134. CAHIC Preventive Medicine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. CAHIC Main Business
Table 136. CAHIC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Preventive Medicine for Pets
Figure 2. Preventive Medicine for Pets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventive Medicine for Pets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Preventive Medicine for Pets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Preventive Medicine for Pets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Preventive Medicine for Pets Sales Market Share by Country/Region (2025)
Figure 10. Preventive Medicine for Pets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Preventive Medicine for Pets Sales Market Share by Type in 2026
Figure 14. Global Preventive Medicine for Pets Revenue Market Share by Type (2021-2026)
Figure 15. Preventive Medicine for Pets Consumed in Cat
Figure 16. Global Preventive Medicine for Pets Market: Cat (2021-2026) & (K Units)
Figure 17. Preventive Medicine for Pets Consumed in Dog
Figure 18. Global Preventive Medicine for Pets Market: Dog (2021-2026) & (K Units)
Figure 19. Preventive Medicine for Pets Consumed in Reptile
Figure 20. Global Preventive Medicine for Pets Market: Reptile (2021-2026) & (K Units)
Figure 21. Preventive Medicine for Pets Consumed in Other
Figure 22. Global Preventive Medicine for Pets Market: Other (2021-2026) & (K Units)
Figure 23. Global Preventive Medicine for Pets Sale Market Share by Application (2025)
Figure 24. Global Preventive Medicine for Pets Revenue Market Share by Application in 2026
Figure 25. Preventive Medicine for Pets Sales by Company in 2026 (K Units)
Figure 26. Global Preventive Medicine for Pets Sales Market Share by Company in 2026
Figure 27. Preventive Medicine for Pets Revenue by Company in 2026 ($ millions)
Figure 28. Global Preventive Medicine for Pets Revenue Market Share by Company in 2026
Figure 29. Global Preventive Medicine for Pets Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Preventive Medicine for Pets Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 32. Americas Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 33. APAC Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 34. APAC Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 35. Europe Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 36. Europe Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 39. Americas Preventive Medicine for Pets Sales Market Share by Country in 2026
Figure 40. Americas Preventive Medicine for Pets Revenue Market Share by Country (2021-2026)
Figure 41. Americas Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 42. Americas Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 43. United States Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Preventive Medicine for Pets Sales Market Share by Region in 2026
Figure 48. APAC Preventive Medicine for Pets Revenue Market Share by Region (2021-2026)
Figure 49. APAC Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 50. APAC Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 51. China Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 55. India Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Preventive Medicine for Pets Sales Market Share by Country in 2026
Figure 59. Europe Preventive Medicine for Pets Revenue Market Share by Country (2021-2026)
Figure 60. Europe Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 61. Europe Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 62. Germany Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 63. France Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 70. Egypt Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Preventive Medicine for Pets in 2026
Figure 76. Manufacturing Process Analysis of Preventive Medicine for Pets
Figure 77. Industry Chain Structure of Preventive Medicine for Pets
Figure 78. Channels of Distribution
Figure 79. Global Preventive Medicine for Pets Sales Market Forecast by Region (2027-2032)
Figure 80. Global Preventive Medicine for Pets Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Preventive Medicine for Pets Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Preventive Medicine for Pets Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Preventive Medicine for Pets Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Preventive Medicine for Pets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Preventive Medicine for Pets
Figure 2. Preventive Medicine for Pets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventive Medicine for Pets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Preventive Medicine for Pets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Preventive Medicine for Pets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Preventive Medicine for Pets Sales Market Share by Country/Region (2025)
Figure 10. Preventive Medicine for Pets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Preventive Medicine for Pets Sales Market Share by Type in 2026
Figure 14. Global Preventive Medicine for Pets Revenue Market Share by Type (2021-2026)
Figure 15. Preventive Medicine for Pets Consumed in Cat
Figure 16. Global Preventive Medicine for Pets Market: Cat (2021-2026) & (K Units)
Figure 17. Preventive Medicine for Pets Consumed in Dog
Figure 18. Global Preventive Medicine for Pets Market: Dog (2021-2026) & (K Units)
Figure 19. Preventive Medicine for Pets Consumed in Reptile
Figure 20. Global Preventive Medicine for Pets Market: Reptile (2021-2026) & (K Units)
Figure 21. Preventive Medicine for Pets Consumed in Other
Figure 22. Global Preventive Medicine for Pets Market: Other (2021-2026) & (K Units)
Figure 23. Global Preventive Medicine for Pets Sale Market Share by Application (2025)
Figure 24. Global Preventive Medicine for Pets Revenue Market Share by Application in 2026
Figure 25. Preventive Medicine for Pets Sales by Company in 2026 (K Units)
Figure 26. Global Preventive Medicine for Pets Sales Market Share by Company in 2026
Figure 27. Preventive Medicine for Pets Revenue by Company in 2026 ($ millions)
Figure 28. Global Preventive Medicine for Pets Revenue Market Share by Company in 2026
Figure 29. Global Preventive Medicine for Pets Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Preventive Medicine for Pets Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 32. Americas Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 33. APAC Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 34. APAC Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 35. Europe Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 36. Europe Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Preventive Medicine for Pets Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Preventive Medicine for Pets Revenue 2021-2026 ($ millions)
Figure 39. Americas Preventive Medicine for Pets Sales Market Share by Country in 2026
Figure 40. Americas Preventive Medicine for Pets Revenue Market Share by Country (2021-2026)
Figure 41. Americas Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 42. Americas Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 43. United States Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Preventive Medicine for Pets Sales Market Share by Region in 2026
Figure 48. APAC Preventive Medicine for Pets Revenue Market Share by Region (2021-2026)
Figure 49. APAC Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 50. APAC Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 51. China Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 55. India Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Preventive Medicine for Pets Sales Market Share by Country in 2026
Figure 59. Europe Preventive Medicine for Pets Revenue Market Share by Country (2021-2026)
Figure 60. Europe Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 61. Europe Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 62. Germany Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 63. France Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Application (2021-2026)
Figure 70. Egypt Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Preventive Medicine for Pets Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Preventive Medicine for Pets in 2026
Figure 76. Manufacturing Process Analysis of Preventive Medicine for Pets
Figure 77. Industry Chain Structure of Preventive Medicine for Pets
Figure 78. Channels of Distribution
Figure 79. Global Preventive Medicine for Pets Sales Market Forecast by Region (2027-2032)
Figure 80. Global Preventive Medicine for Pets Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Preventive Medicine for Pets Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Preventive Medicine for Pets Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Preventive Medicine for Pets Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Preventive Medicine for Pets Revenue Market Share Forecast by Application (2027-2032)
